Argenx Se ARGX
NASDAQ ARGX
$1,038.25 -15.21 (-1.44%)
As of: Sep 4, 2026 · 10:48 AM EDT

Argenx Se (ARGX) EBT (2016 - 2026)

Argenx Se's (ARGX) quarterly EBT came in at $541.0 million in Q2 2026, up 88.57% YoY from $286.9 million in Q2 2025, and up 23.52% on a QoQ basis from $438.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) EBT (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has 11 years of EBT data on file, last reported at $541.0 million in Q2 2026.

  • Quarterly EBT rose 88.57% year-over-year to $541.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (up 167.47% YoY) and the FY2025 annual result came in at $1.3 billion, up 1401.06% from the prior year.
  • EBT climbed to $541.0 million in Q2 2026, from $438.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $541.0 million in Q2 2026 to a low of -$241.0 million in Q3 2022.
  • A 5-year average of $72.6 million and a median of -$28.1 million in 2022 frame the typical range for EBT.
  • Annual changes were most pronounced in 2022 — EBT sank 886.6% — and 2025, when it soared 2012.28%.
  • Tracing ARGX's EBT over 5 years: stood at -$41.2 million in 2022, then sank by 48.35% to -$61.2 million in 2023, then soared by 237.06% to $83.9 million in 2024, then soared by 380.97% to $403.3 million in 2025, then jumped by 34.15% to $541.0 million in 2026.
  • The last three EBT figures came in at $541.0 million (Q2 2026), $438.0 million (Q1 2026), and $403.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Vertex Pharmaceuticals 139.79 Bn 131.94 Bn 2.84 Bn 1.39 Bn
2 Regeneron Pharmaceuticals 85.93 Bn 77.94 Bn 3.93 Bn 1.53 Bn
3 Argenx Se 63.75 Bn 58.57 Bn 1.37 Bn 542.00 Mn
4 Moderna 57.29 Bn 52.15 Bn 52.00 Mn -767.00 Mn
5 Revolution Medicines 44.01 Bn 44.01 Bn - -644.37 Mn
6 BeOne Medicines 40.08 Bn 34.98 Bn 1.53 Bn 312.46 Mn
7 Alnylam Pharmaceuticals 35.24 Bn 31.93 Bn 992.69 Mn 177.81 Mn
8 Royalty Pharma 28.60 Bn 27.77 Bn - 81.49 Mn
9 Insmed 27.50 Bn 26.34 Bn 358.27 Mn -11.37 Mn
10 Incyte 25.50 Bn 20.96 Bn 1.57 Bn 751.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 542.00 Mn
Mar 31, 2026 439.00 Mn
Dec 31, 2025 403.29 Mn
Sep 30, 2025 386.05 Mn
Jun 30, 2025 286.90 Mn
Mar 31, 2025 202.36 Mn
Dec 31, 2024 83.85 Mn
Sep 30, 2024 88.02 Mn
Jun 30, 2024 -15.00 Mn
Mar 31, 2024 -74.35 Mn
Dec 31, 2023 -61.18 Mn
Sep 30, 2023 -83.28 Mn
Jun 30, 2023 -83.86 Mn
Mar 31, 2023 -76.18 Mn
Dec 31, 2022 -41.24 Mn
Sep 30, 2022 -241.02 Mn
Jun 30, 2022 -216.98 Mn
Mar 31, 2022 -230.07 Mn
Dec 31, 2021 -244.88 Mn
Sep 30, 2021 -230.87 Mn